X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (45) 45
index medicus (43) 43
humans (41) 41
female (38) 38
male (37) 37
middle aged (36) 36
adult (31) 31
aged (30) 30
oncology (23) 23
transplantation (20) 20
prognosis (18) 18
retrospective studies (17) 17
leukemia (15) 15
chemotherapy (14) 14
japan (14) 14
leukemia-lymphoma, adult t-cell - mortality (14) 14
lymphoma (14) 14
cancer (13) 13
leukemia-lymphoma, adult t-cell - therapy (13) 13
leukemia/lymphoma (13) 13
adolescent (12) 12
aged, 80 and over (12) 12
stem cells (12) 12
t cells (12) 12
transplantation, homologous (12) 12
young adult (12) 12
analysis (11) 11
hematopoietic stem cells (11) 11
lymphomas (11) 11
medicine & public health (11) 11
survival (10) 10
survival rate (10) 10
treatment outcome (10) 10
bone-marrow-transplantation (9) 9
immunology (9) 9
hematopoietic stem cell transplantation (8) 8
remission induction (8) 8
risk factors (8) 8
survival analysis (8) 8
abridged index medicus (7) 7
acute myeloid-leukemia (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
disease-free survival (7) 7
hematology, oncology and palliative medicine (7) 7
kaplan-meier estimate (7) 7
leukemia-lymphoma (7) 7
research (7) 7
disease progression (6) 6
follow-up studies (6) 6
impact (6) 6
intensity (6) 6
japan - epidemiology (6) 6
leukemia-lymphoma, adult t-cell - drug therapy (6) 6
lymphocytes t (6) 6
non-hodgkins-lymphoma (6) 6
antineoplastic agents - therapeutic use (5) 5
atl (5) 5
care and treatment (5) 5
central nervous system (5) 5
combined modality therapy (5) 5
leukemia-lymphoma, adult t-cell - pathology (5) 5
medical colleges (5) 5
prognostic index (5) 5
remission (5) 5
rituximab (5) 5
versus-host-disease (5) 5
combination (4) 4
cord blood transplantation (4) 4
cyclophosphamide - therapeutic use (4) 4
doxorubicin - therapeutic use (4) 4
elderly-patients (4) 4
expression (4) 4
graft vs host disease - etiology (4) 4
hematopoietic stem cell transplantation - methods (4) 4
infection (4) 4
interferon-alpha (4) 4
internal medicine (4) 4
leukaemia/lymphoma (4) 4
leukemia, myeloid, acute - mortality (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
lymphoma, large b-cell, diffuse - mortality (4) 4
mogamulizumab (4) 4
mortality (4) 4
multivariate analysis (4) 4
mutation (4) 4
oncology, experimental (4) 4
outcomes (4) 4
prophylaxis (4) 4
prospective studies (4) 4
unrelated donors (4) 4
vincristine - therapeutic use (4) 4
virus type-i (4) 4
acute disease (3) 3
acute myelogenous leukemia (3) 3
acute myeloid leukemia (3) 3
allogeneic hematopoietic cell transplantation (3) 3
antibodies, monoclonal, murine-derived (3) 3
antibody (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Hematology, ISSN 0925-5710, 11/2018, Volume 108, Issue 5, pp. 516 - 523
Adult T-cell leukemia–lymphoma (ATL) is a distinct T-cell malignancy caused by human T-cell leukemia virus type-1; the prognosis is very poor. Mogamulizumab... 
Oncology | ATL | Mogamulizumab | Medicine & Public Health | Hematology | Prognostic factors | PROGNOSTIC INDEX | COMBINATION CHEMOTHERAPY | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | CCR4 | Lymphomas | Prognosis | Biological products | T cells | Leukemia | Calcium | Viruses | Lactate dehydrogenase | Lymphocytes T | Malignancy | Lymphoma | Patients | L-Lactate dehydrogenase | Calcium (blood) | Medical prognosis | Lactic acid | Index Medicus
Journal Article
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 2019, Volume 54, Issue 9, pp. 1399 - 1405
A dose-intensified multi-agent chemotherapy regimen called VCAP-AMP-VECP was investigated in Japan as front-line therapy for patients with adult T-cell... 
PROGNOSTIC INDEX | ONCOLOGY | LEUKEMIA/LYMPHOMA | IMMUNOLOGY | MOGAMULIZUMAB | COMBINATION | HEMATOLOGY | TRANSPLANTATION | Chemotherapy | Multiagent systems | AMP | Risk groups | Leukemia | Risk | Lymphomas | Lymphocytes T | Lymphoma
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 28, pp. 3426 - 3433
Journal Article
Internal Medicine, ISSN 0918-2918, 2017, Volume 56, Issue 14, pp. 1873 - 1877
Journal Article
Leukemia Research Reports, ISSN 2213-0489, 2019, Volume 11, pp. 27 - 30
A 17-year-old male received allogeneic transplantation for acute lymphoblastic leukemia, and presented with generalized seizures due to a solitary brain lesion... 
Post-transplant lymphoproliferative disorder | Allogeneic hematopoietic stem cell transplantation | Epstein–Barr virus | Central nervous system
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
Blood, ISSN 0006-4971, 08/2010, Volume 116, Issue 8, pp. 1211 - 1219
Journal Article
Journal Article
Journal Article
Journal Article